Interpore Cross
This article was originally published in The Gray Sheet
Executive Summary
Company plans to launch this year a cervical corpectomy cage intended to replace portions of the spine removed due to cancer. The company submitted a Humanitarian Device Exemption in late 1999 for the Class III device and anticipates FDA approval sometime in the first quarter, Chairman and CEO David Mercer reports at the recent U.S. Bancorp Piper Jaffray Health Care conference in New York City